Nicholas Investment Partners, LP Abiomed Inc Transaction History

Nicholas Investment Partners, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$250.96 - $284.94 $4.67 Million - $5.31 Million	-18,624 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $2.59 Million - $3.39 Million	-9,360 Reduced 33.45%	18,624 $5.32 Million
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $838,742 - $1.33 Million	2,984 Added 11.94%	27,984 $9.1 Million
Q3 2018 Nov 14, 2018	SELL	$354.53 - $449.75 $11.1 Million - $14.1 Million	-31,372 Reduced 55.65%	25,000 $11.2 Million
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $823,365 - $1.32 Million	-2,961 Reduced 4.99%	56,372 $23.1 Million
Q1 2018 May 15, 2018	SELL	$192.49 - $295.85 $1.83 Million - $2.81 Million	-9,484 Reduced 13.78%	59,333 $17.3 Million
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $387,687 - $458,802	-2,297 Reduced 3.23%	68,817 $12.9 Million
Q3 2017 Nov 13, 2017	BUY	$145.39 - $168.6 $10.3 Million - $12 Million	71,114	71,114 $12 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.